UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A succinct guide to identifying the ETF with the best tax efficiency for dividend exposure, including key considerations and quick decision tips.
28,132 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Mastercard unveiled a large partner program to weave stablecoins and tokenized dollars into its payments network, a m...
A Mexican anti-money laundering move froze a bank account tied to a Miss Universe co-owner as authorities pursue a wi...
A private AI-focused XR company invites retail investors to participate in a sub-$1 pre-IPO round, offering bonus sha...
A federal jury awarded $3 million to a woman in the first-ever social media addiction trial against Meta and Google, ...
Bitcoin continues its climb for the month, pressing into a critical resistance zone. Traders await a confirmed breako...
A rare can shortage is turning a familiar cola into a symbol of status in India’s urban youth. This story examines ho...
The Senate Banking Committee advances toward Thursday's CLARITY Act markup amid a surge of amendments and lobbying, s...
A leading CIO cautions that AI stock valuations may be stretched beyond sustainable growth. The article surveys what ...
The NHL and CFTC have agreed to study licensed, crypto-backed sports prediction markets under a new memorandum of und...
A rapid-growth software startup markets a scrolling-based monetization model and seeks pre-IPO investors at $0.50 a s...
Ethereum trades near the $2,000 mark as institutional moves diverge: BitMine increases ETH holdings while BTC exposur...